课题基金 / 基金详情

Preventing Injecting by Modifying Existing Responses (PRIMER)

Preventing Injecting by Modifying Existing Responses (PRIMER)
通过修改现有响应来防止注入 (PRIMER)
批准号:
340870
负责人:
Werb Daniel M
金额:
$21.86万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-12-01 至 2020-12-01

项目摘要

项目成果

Werb Daniel M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Injection drug use remains a primary source of HIV transmission globally, and people who inject drugs (PWID) have been shown to play a key role in the initiation of others into injecting. However, no interventions to prevent injecting initiation are prove
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Toronto Disparities, Overdose, and Treatment (T-DOT) Study: Investigating clinical outcomes among people who inject drugs during a period of rapid programmatic and policy change
  • 批准号:
    462231
  • 项目类别:
    Operating Grants
  • 资助金额:
    $113.69万
  • 财政年份:
    2022
  • 负责人:
    Werb Daniel M
  • 依托单位:
Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto
  • 批准号:
    430301
  • 项目类别:
    Operating Grants
  • 资助金额:
    $15.06万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
Preventing Injecting and Overdose by Disrupting Injection Drug Use Transitions: The PRIMER II Study
  • 批准号:
    434750
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.45万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
海外基金